Lance Berberian - Aug 5, 2024 Form 4 Insider Report for LABCORP HOLDINGS INC. (LH)

Role
EVP, CIO & CTO
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Lance Berberian
Stock symbol
LH
Transactions as of
Aug 5, 2024
Transactions value $
-$2,770,552
Form type
4
Date filed
8/7/2024, 08:47 AM
Previous filing
Mar 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Sale -$516K -2.25K -8.01% $229.79 25.8K Aug 5, 2024 Direct F1
transaction LH Common Stock Sale -$2.25M -9.85K -38.22% $228.95 15.9K Aug 5, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price of $229.785 per share represents a weighted average of sales prices ranging from $229.74 to $229.87 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
F2 The price of $228.9485 per share represents a weighted average of sales prices ranging from $228.53 to $229.525 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.

Remarks:

On May 17, 2024, Labcorp Holdings Inc. ("LHI") became the successor of Laboratory Corporation of America Holdings ("LCAH") pursuant to LCAH's reorganization into a new holding company structure (the "Reorganization"). The Reorganization resulted in LHI becoming a parent holding company of LCAH but did not alter the proportionate interests of LCAH security holders.